Brain oxygen measurement for preterm infants
Preterm birth and its subsequent consequences are the leading cause of death for children under five years of age worldwide. Every year, 15 million infants are born prematurely, and inadequate oxygenation is the leading cause of neonatal death. With real time, precise, and accurate brain oxygen monitoring, medical teams can react before damage occurs.
During their time at Wyss Zurich, the OxyPrem team developed a next-generation medical device, NOAH, that monitors brain oxygen levels of preterm infants in real time using harmless, non-invasive near-infrared light. The device continuously measures local oxygenation with the precision and accuracy required to assist in clinical decision-making for these high-risk patients. Additionally, the team introduced the NOAH device to clinical care in over 30 hospitals in six European countries as part of a large-scale multicenter clinical study accelerating the medical community’s efforts to make brain oxygen measurement a standard component of clinical care.
Faculty Mentor
